麻豆传媒

Clinical trials of xenotransplantation expected to kick off next year

With a potentially deadly recall, case highlights shortcomings in overseas drug manufacturing

It might even help, researchers say

More patients taking sodium zirconium cyclosilicate achieved normokalemia vs placebo recipients

Accuracy above 85% in early testing -- far better than proteinuria and biopsy

Also in TTHealthWatch: frailty as a predictor of dementia

Data too uncertain to support sotagliflozin in subset with chronic kidney disease, advisors say

Health news and commentary gathered by 麻豆传媒 staff

SGLT1/SGLT2 inhibitor has another shot in T1D, but now in more narrow patient population

Deadly E. coli outbreak has been tentatively traced to contaminated onions

However, 24 weeks of the GLP-1 had no impact on eGFR

Personalized recs were made by team of physicians and pharmacists within an hour of diagnosis

Trial follow-up defines the need for long-term treatment in protecting the kidneys and heart

Observational study points to genetic risk allele dose-response